Best of all, we achieved remarkable debulking of both lesions using one pass with a single catheter. Also, the built-in aspiration feature virtually eliminated any risk of distal embolization and allowed me to complete the case without the use of additional embolic protection. The B-Laser system’s ability to lase in blood with contrast media significantly enhances ease of use and helped speed up case time. Beyond the impressive clinical and safety data, I found the system to be far smaller, has virtually no warm-up time, and is more convenient than competitive systems. Weinstock commented in the company's announcement, “Having participated in the United States study as an investigator and seen the impressive efficacy and safety data Eximo’s B-Laser system was able to generate in a wide variety of challenging lesions, I was extremely excited to perform the first commercial procedure. announced the launch and first commercial use of its B-Laser atherectomy system for treatment of peripheral vascular disease.īarry Weinstock, MD, who is with Orlando Heart & Vascular Institute and Director of the catheterization laboratory at the Center for Cardiovascular Excellence in Orlando, Florida, used the B-Laser atherectomy system to successfully treat a patient with severe in-stent restenosis in the superficial femoral artery as well as a critical de novo stenosis in the proximal popliteal artery.ĭr.

Www eximo de